From what I've seen, they're doing a great job of marketing on a shoe string budget, but I know what you're saying. In time we'll see them able to allocate much more capital to marketing. If they get over zealous with it now, they'd be going too far for two very important reasons:
First, you need to already have large geographic areas covered with retail distribution, which they can only chip away at right now until the FDA is done with their Chicken Little speculation and moves to provide reasonable preliminary guidelines based on what clinical evidence does exist. Otherwise, you're spending big bucks to advertise something that most consumers will not be able to find except for direct online sales. Fortunately, that business has picked up big time in recent years, but retail distribution is critical for foods and beverages. You need both really.
Second, it's expensive to launch big marketing campaigns, and at this point the result would be dilution on a scale that would NOT see us getting more in return than what was invested. Definitely not prior to having retail distribution channels set up in most of the country, but they're working on it. Some areas will be slow to be CBD friendly until the FDA is done stalling for big pharma.
They appear to be balancing their initiatives to their available capital very wisely at this point. As revenues ramp up I'm sure that more and more capital will be channeled into marketing strategies. We'll get a great deal of it however, just from the well established partners we're doing business with. Especially CBD Life, which is why I reminded people of the "Powered by Rocky Mountain High" printed in a very readily visible fashion on every single can of Rocket High and California beverages. A lot of investors should be very surprised at how well RMHB does in 2020.
First, you need to already have large geographic areas covered with retail distribution, which they can only chip away at right now until the FDA is done with their Chicken Little speculation and moves to provide reasonable preliminary guidelines based on what clinical evidence does exist. Otherwise, you're spending big bucks to advertise something that most consumers will not be able to find except for direct online sales. Fortunately, that business has picked up big time in recent years, but retail distribution is critical for foods and beverages. You need both really.
Second, it's expensive to launch big marketing campaigns, and at this point the result would be dilution on a scale that would NOT see us getting more in return than what was invested. Definitely not prior to having retail distribution channels set up in most of the country, but they're working on it. Some areas will be slow to be CBD friendly until the FDA is done stalling for big pharma.
They appear to be balancing their initiatives to their available capital very wisely at this point. As revenues ramp up I'm sure that more and more capital will be channeled into marketing strategies. We'll get a great deal of it however, just from the well established partners we're doing business with. Especially CBD Life, which is why I reminded people of the "Powered by Rocky Mountain High" printed in a very readily visible fashion on every single can of Rocket High and California beverages. A lot of investors should be very surprised at how well RMHB does in 2020.
9
1
